Potential Benefits of ETI Therapy for Non-CF Bronchiectasis with CFTR Dysfunction
發布者：Unknown
·發布於：2025-12-13
Discussion regarding how elexacaftor/tezacaftor/ivacaftor (ETI) therapy might benefit patients diagnosed with non-cystic fibrosis bronchiectasis who exhibit CFTR dysfunction.
載入中...